SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-001475
Filing Date
2018-02-07
Accepted
2018-02-07 12:27:16
Documents
88
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q - QUARTER ENDED 12/31/17 mygn-10q_20171231.htm 10-Q 2443850
2 EX-31.1 mygn-ex311_6.htm EX-31.1 15851
3 EX-31.2 mygn-ex312_9.htm EX-31.2 16330
4 EX-32.1 mygn-ex321_8.htm EX-32.1 6527
  Complete submission text file 0001564590-18-001475.txt   9912066

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mygn-20171231.xml EX-101.INS 2632071
6 XBRL TAXONOMY EXTENSION SCHEMA mygn-20171231.xsd EX-101.SCH 55488
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20171231_cal.xml EX-101.CAL 77271
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20171231_def.xml EX-101.DEF 149839
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20171231_lab.xml EX-101.LAB 412845
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20171231_pre.xml EX-101.PRE 332267
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 18580141
SIC: 2835 In Vitro & In Vivo Diagnostic Substances